Loading...
Treatment free remission in chronic myeloid leukemia: Lights and shadows
In addition to the best possible overall survival, discontinuation of the tyrosine kinase-inhibitor (TKI) treatment [treatment free remission (TFR)] without observing a recurrence of the disease has become a standard part of chronic myeloid leukemia (CML) care. Worldwide, more than 2000 patients wit...
Na minha lista:
| Udgivet i: | Hematol Rep |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
PAGEPress Publications, Pavia, Italy
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7520857/ https://ncbi.nlm.nih.gov/pubmed/33042501 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2020.8950 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|